Symptom Advice .com » tarrytown http://symptomadvice.com Tue, 29 May 2012 22:17:13 +0000 en hourly 1 http://wordpress.org/?v=3.0.1 EpiCept Reports Positive Results from EpiCept™ NP-1 Trial in Patients with Chemotherapy-Induced Peripheral Neuropathy http://symptomadvice.com/epicept-reports-positive-results-from-epicept%e2%84%a2-np-1-trial-in-patients-with-chemotherapy-induced-peripheral-neuropathy/ http://symptomadvice.com/epicept-reports-positive-results-from-epicept%e2%84%a2-np-1-trial-in-patients-with-chemotherapy-induced-peripheral-neuropathy/#comments Mon, 07 Feb 2011 23:34:13 +0000 Symptom Advice http://symptomadvice.com/epicept-reports-positive-results-from-epicept%e2%84%a2-np-1-trial-in-patients-with-chemotherapy-induced-peripheral-neuropathy/

Press Release Source: EpiCept Corporation on Monday February 7, 2011, 12:01 am EST

TARRYTOWN, N.Y.–(BUSINESS WIRE)– Regulatory News:

EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced positive results from a Phase IIb trial evaluating the efficacy and safety of EpiCept™ NP-1 (NP-1) in chemotherapy-induced peripheral neuropathy (CPN). EpiCept NP-1 is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

the multi-center, double-blind, randomized, placebo-controlled study was conducted by the National Cancer Institute (NCI)-funded Community Clinical Oncology Program. More than 460 cancer survivors suffering from painful CPN were enrolled in the six-week study. the results of the trial in the intent to treat (ITT) population demonstrated that the change in average daily neuropathy intensity scores in the NP-1 group achieved a statistically significant reduction in CPN intensity versus placebo (p

]]> http://symptomadvice.com/epicept-reports-positive-results-from-epicept%e2%84%a2-np-1-trial-in-patients-with-chemotherapy-induced-peripheral-neuropathy/feed/ 0